Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide  by Narula, SS et al.
Solution structure of the C-terminal SH2 domain of the
human tyrosine kinase Syk complexed with a
phosphotyrosine pentapeptide
SS Narula, RW Yuan, SE Adams, OM Green, J Green, TB Philips,
LD Zydowskyt, MC Botfield, M Hatada, ER Laird, MJ Zoller,
JL Karas and DC Dalgarnol*
Ariad Pharmaceuticals Inc., Cambridge, MA 02139, USA
Background: Recruitment of the intracellular tyrosine
kinase Syk to activated immune-response receptors is
a critical early step in intracellular signaling. In mast
cells, Syk specifically associates with doubly phosphory-
lated immunoreceptor tyrosine-based activation motifs
(ITAMs) that are found within the IgE receptor. The
mechanism by which Syk recognizes these motifs is not
fully understood. Both Syk SH2 (Src homology 2)
domains are required for high-affinity binding to these
motifs, but the C-terminal SH2 domain (Syk-C) can
function independently and can bind, in isolation, to the
tyrosine-phosphorylated IgE receptor in vitro. In order to
improve understanding of the cellular function of Syk, we
have determined the solution structure of Syk-C com-
plexed with a phosphotyrosine peptide derived from the
y subunit of the IgE receptor.
Results: The Syk-C:peptide structure is compared with
liganded structures of both the SH2 domain of Src and
the C-terminal SH2 domain of ZAP-70 (the 70 kDa
zeta-associated protein). The topologies of these domains
are similar, although significant differences occur in the
loop regions. In the Syk-C structure, the phospho-
tyrosine and leucine residues of the peptide ligand inter-
act with pockets on the protein, and the intervening
residues are extended.
Conclusions: Syk-C resembles other SH2 domains in its
peptide-binding interactions and overall topology, a result
that is consistent with its ability to function as an inde-
pendent SH2 domain in vitro. This result suggests that
Syk-C plays a unique role in the intact Syk protein. The
determinants of the binding affinity and selectivity of
Syk-C may reside in the least-conserved structural ele-
ments that comprise the phosphotyrosine- and leucine-
binding sites. These structural features can be exploited
for the design of Syk-selective SH2 antagonists for the
treatment of allergic disorders and asthma.
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Introduction
Syk is an intracellular protein tyrosine kinase expressed in
a variety of hematopoietic cells including mast cells, B
cells, macrophages, platelets, and thymocytes [1-5]. The
role of Syk in receptor-mediated signaling has been best
characterized for immune-response receptors. Syk cou-
ples with the IgE and IgM receptors in mast cells and
B cells, respectively, is activated after engaging with the
respective receptor, and thereby plays a critical role in
mediating cellular responses [1,6-13]. Syk is also acti-
vated following engagement of Fcy receptors in
myelomonocytic cells [14].
Syk is a 70 kDa protein [15] which is closely related to
the 70 kDa zeta-associated protein, ZAP-70, a tyrosine
kinase that is essential for the activation of T-cell receptors
[16]. Syk and ZAP-70 belong to a unique class
of tyrosine kinases that have two Src homology 2 (SH2)
domains, and a catalytic domain. SH2 domains contain
approximately 100 amino acids and have been found in
cytosolic tyrosine kinases, phosphotyrosine phos-phatases,
and a number of other proteins that play key roles in
signal transduction [17]. These SH2 domains bind with
high affinity to specific phosphorylated tyrosines in pro-
teins. The tandem SH2 domains ofSyk bind to sequences
within the cytoplasmicdomains of receptors on immune
cells. These motifs are termed immunoreceptor tyrosine
based activation motifs (ITAMs) [18,19] and contain the
sequenceTyr-X-X-Leu-X-X-X-X-X-X--Tr-X-X
-Leu (where X is any amino acid), which becomes tyro-
sine phosphorylated upon receptor activation, creating
ligands (underlined) for the two SH2 domains of Syk.
This SH2-mediated association of Syk with an activated
receptor stimulates Syk kinase activity and localizes Syk to
the plasma membrane. Although Syk contains two SH2
domains, in vitro binding studies on isolated N- and
C-terminal SH2 domains demonstrate that only the
C-terminal SH2 domain binds to phosphotyrosine, and
only this SH2 domain can affinity purify the IgE-receptor
complex from activated mast cell lysates. These results
demonstrate that the N- and C-terminal SH2 domains
are functionally distinct and suggest that each SH2
domain plays a unique role in the recognition of the IgE
receptor, by Syk, in immune cells [20,21].
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The structures of several isolated SH2 domains, and their
complexes with phosphopeptides, have been determined
by both nuclear magnetic resonance (NMR) spec-
troscopy and X-ray crystallography [22-31]. In addition,
the structures of SH3-SH2 and SH3-SH2-SH3 proteins
have been described [32,33]. Recently, the structure of
the tandem SH2 domains of ZAP-70 in complex with a
phosphopeptide has been reported [34]. In each case, the
overall tertiary folds of the SH2 domains are conserved
(Fig. 1). The general topology consists of a large, triple-
stranded, central 3 sheet that is flanked by two t helices,
with a secondary triple-stranded 3 sheet also being
observed. One edge of the central P3 sheet acts to separate
the ligand-binding site into two distinct pockets or
grooves, one to accommodate the phosphotyrosine
(pTyr) and the other to accommodate a lipophilic amino
acid. The interaction of SH2 domains with phosphory-
lated peptides has been described as being reminiscent of
the fit between a 'socket and plug' [29].
Recognition sequences for SH2 domains have been
identified by screening libraries of randomized phospho-
peptides. The results suggest that the three residues
C-terminal to the pTyr (referred to as pTyr+l, pTyr+2,
and pTyr+3) are the principal determinants of peptide
selectivity among different SH2 domains [35,36]. Use of
these methods for the analysis of ligand selectivity by
Syk-C has lead to the classification of Syk-C as a group I
SH2 domain, this group representing SH2 domains that
select peptides of the general sequence pTyr-hydro-
philic-hydrophilic-hydrophobic.
The ITAM present in the y chain of the FcERI receptor
(the high-affinity IgE receptor) contains two SH2 bind-
ing motifs which are pTyr-Thr-Gly-Leu (pTyr65 motif)
and pTyr-Glu-Thr-Leu (pTyr76 motif) [37]. It is not
known which of these peptide motifs binds to the
C-terminal SH2 domain of Syk in vivo.
Elucidation of the three-dimensional (3D) structure of
Syk tyrosine kinase is crucial for understanding the func-
tion of this protein on a molecular level, and will aid in
the design of mechanism-based therapeutics for allergy
and asthma. Although several structural studies have
already described the overall tertiary fold of SH2
domains and the nature of the SH2:pTyr peptide inter-
action, it is clear that a thorough understanding of the
mode of peptide binding within individual SH2 domains
requires information at the molecular level. Here, we
describe the NMR solution structure of the C-terminal
SH2 domain of human tyrosine kinase Syk (Syk-C)
in complex with the phosphotyrosine peptide
Ac-Thr-pTyr-Glu-Thr-Leu-NH 2 (corresponding to
the pTyr76 peptide in the y chain of the FceRI receptor
[FcERI-Y], a native Syk ligand). This is the first report of
the structure of a complex between a Syk tyrosine kinase
SH2 domain and its ligand.
Results
Syk-C binds to ITAM-derived phosphopeptides
To identify the optimal peptide ligand for structural stud-
ies, purified Syk-C was tested for its ability to bind to
ITAM-derived phosphopeptides from the high-affinity
IgE receptor, using surface plasmon resonance (Fig. 2).
Little sequence preference is evident although the short
peptides based on, and including, the pTyr76 motif of
FcERIy, bind with higher affinity than those derived
from the pTyr65 motif of FceRIy and the pTyr motifs in
FceRI3 (data not shown). Syk-C exhibits no detectable
binding to similar peptides that lack phosphotyrosine
(data not shown).
NMR analysis of the Syk-C:pTyr76 peptide complex
Protein: peptide interactions can be studied using isotope
filtering NMR methods on complexes formed between
uniformly 15N/13 C-labeled proteins and unlabeled target
ligands [38,39]. This strategy was utilized to study the
interaction between 15N/13 C-labeled Syk-C and the
unlabeled pTyr76 peptide (Ac-Thr-pTyr-Glu-Thr-
Leu-NH 2). Studies of the complex were carried out
using 2-4 mM protein (Syk-C) samples in 50 mM Tris-
dill, 0.15 N NaCl, 10mM dithiothreitol-d1 0 (DTT),
at 20 °C and pH 7.0. Preliminary titration experiments
Fig. 1. Sequences for selected SH2
domains - v-Src (avian Src SH2), c-Src
(human Src SH2), Syk-C (human Syk
C-terminal SH2), ZAP-C (human ZAP-
70 C-terminal SH2) PLCy1-C (bovine
phospholipase C-'y1 C-terminal SH2-
aligned according to the secondary
structure definitions of Src SH2 and
using the nomenclature of Eck et al.
[23]. The first residue in the alignment
corresponds to Trpl 5 of the Syk-C con-
struct reported here and Trp168 for the
full sequence of human Syk. Secondary
structural regions specific to Syk-C SH2
are highlighted in gray. Residues in
v-Src that are implicated in binding to
phosphotyrosine-containing peptides
are highlighted in green (residues that
contact pTyr), red (pTyr+l), yellow(pTyr+2), and purple (pTyr+3) 129].
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Fig. 2. Relative binding affinities of the FcERI receptor y chain ITAM phosphopeptides, determined using surface plasmon resonance.
The IC50 is the concentration of inhibitor ligand required to achieve a 50% reduction in the binding of Syk-C to an immobilized ITAM
peptide (see the Materials and methods section).
indicated that addition of the peptide to labeled protein
samples resulted in the broadening or disappearance of a
number of protein resonances in the 'H-' 5 N hetero-
nuclear single quantum (HSQC) spectrum [40], which
sharpened when the protein was saturated with peptide.
Continued addition of peptide to such samples resulted
in the broadening of unlabeled peptide NH resonances in
the H-15N isotope-filtered spectrum [38] of the com-
plex. Such broadening is characteristic of intermediate
chemical-exchange behavior and it was necessary to take
particular care in sample preparation. Samples for detailed
study were prepared by ultrafiltration of mixtures of
excess peptide and protein, and these were then analyzed
by 2D NMR to ensure that a 1:1 (protein:peptide)
complex was present.
The sequential NMR assignment of the Syk-C:pTyr76
peptide was carried out by the application of through-
bond heteronuclear NMR correlation experiments on
complexes formed from uniformly 1 5 N/1 3C-labeled pro-
tein. Sequential NMR assignments made on the uncom-
plexed form of Syk-C, obtained at under different solution
conditions, were used, in combination with various exper-
iments involving the correlations between the Ca, C[, N
and NH of current and the Ca and C3 of preceding
amino-acid residues, to obtain the sequential resonance
assignments of the complexed form of the protein [41,42].
Additional protein side-chain assignments were made
using heteronuclear correlation experiments [43,44]. A
fractionally 1 3 C-labeled sample of Syk-C was used to
obtain stereospecific methyl group assignments for valine
and leucine residues [45]. 1H resonance assignments for
the bound peptide were obtained from 2D isotope-filtered
datasets [38,46]. A representative dataset, in the form of an
isotope-filtered nuclear Overhauser effect (NOESY)
spectrum, is shown in Figure 3.
3D and 4D NOESY experiments were used to obtain
1340 intraprotein distance constraints [44]; 2D isotope-
filtered data were used to obtain 63 intrapeptide distance
constraints; and 55 peptide:protein distance constraints
were derived from 2D and 3D isotope-filtered datasets
[38,47]. The distribution of these constraints is summa-
rized in Figure 4. The preferred values for 47 protein
backbone dihedral angles, were obtained by analyzing the
results of a 3D HNHa experiment [48].
3D structures were computed by utilizing a combined
distance-geometry/simulated-annealing protocol within
the program X-PLOR 3.1 [49]. A family of 20 structures
was selected, none of which had any NOE violations
greater than 0.5 A or torsion-angle violations greater
than 5, and all showed very low deviation from ideal
covalent geometry.
The superimposition of the backbone (N, Ca, C) traces of
the final 20 NMR structures of the complex is shown in
Figure 5a. For clarity, only the peptide and residues
Trp15-Ile106 of the protein, are shown. Protein residues
outside this region are unstructured. All of the structures
show two well defined ao helices (otA and otB) flanking a
central, triple-stranded [3 sheet (B, C, and 3D)
(Tables 1, 2). The a helix and 3 sheet nomenclature uses
the convention established for the SH2 domains of Lck
and Src [23,29] in which residue position and identity are
Fig. 3. A portion of the 2D 15N/3C isotope-filtered nuclear Over-
hauser effect (NOESY) spectrum (100 ms mixing time) of the15N/13C Syk-C:pTyr76 peptide complex. 15N/13C isotope filter-
ing was applied in both the fl and f2 dimensions, therefore only
peptide: peptide NOEs are observed [38]. A number of peaks are
labeled with the names of the protons participating in the NOE
interactions.
Peptide Sequence IC5 0
pTyr65 motif pTyr76 motif
Ac-Asp-Gly-Val-- pTyr-Thr-Gl--Leu-Ser-Thr-Arg-Asn-Gln-Glu-Thr-pTvr-Glu-Thr-Leu-LysNH 2 32M
Ac- DTr-Thr-Gly-Leu -NH2 48p M
Ac- Val-.Tyr-Thr-Gl-Leu -NH2 30 M
Ac- Thr-pTvr-Glu-Thr-Leu -NH2 20pJM
Ac- Tvr-Glu-Thr-Leu -NH2 25pM
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Fig. 4. Distribution of NOE constraints used in the structure calculations. The height of each bar reflects the total number of NOE-
derived constraints for that residue. All of the NOEs are divided into four categories, that is, intraresidue, sequential, medium, and long
range 1691. For the purpose of the calculation all protein:peptide NOEs are classified as long range. Residues 1-5 arise from the pTyr76
peptide; only residues 10-112 of Syk-C are shown. The positions of secondary structural elements present in the Syk-C complex are
indicated schematically beneath the NOE diagram.
described in terms of consensus secondary structural
elements (Fig. 1). Residues spanning these structural
elements are well constrained by the experimentally
observed NOEs (Fig. 4). The root mean square (rms)
deviation for the backbone heavy atoms of the 20 struc-
tures is 1.17 A (residues Trpl5-Cys106; Table 2). The
backbone rms deviation for the central triple-stranded 3
sheet is 0.43 A, with the backbone rms deviations for the
two helices, otA and oxB, being 0.17 A and 0.09 A, respec-
tively. The rms deviations for the peptide and binding
interface are 0.24 A and 0.42 A, respectively (Table 2).
Topology of Syk-C: pTyr76 peptide
The overall topology of the Syk-C complex is similar to
that described for the SH2 domains whose structures
have been reported. Figure 5b shows a ribbon diagram of
the restrained, minimized, mean structure of the com-
plex showing the protein backbone, the bound peptide,
and selected protein side chains. In the calculated struc-
tures, residues 15-106 exhibit well defined conforma-
tions. This structured region corresponds closely to the
sequence defined as the SH2 domain (Fig. 1) as it consists
of a central [3 sheet flanked on either side by an at helix
(otA and oB). The central sheet is composed of three
strands, termed S3B (Lys38-Ala43), 3PC (Tyr50-Leu55),
and 13D (Lys59-Ile65), which are connected by at least
nine hydrogen bonds, as shown by their slowly exchang-
ing backbone NH protons. Both the atA helix
(Arg22-Ile31) and the oiB helix (Thr83-Lys94) are char-
acterized by six hydrogen bonds. The short 3 strand, 3A,
that precedes the first helix, is not well defined in Syk-C.
There is also a smaller secondary 3 sheet composed of
three strands - PD' (Asp66-Asp68), 3E (Lys72-Ile75)
and 3F (Lys79-Phe81) - connected by at least three hy-
dro-gen bonds. An extended region (Va104-Cys106),
corresponding to the [3G strand in Src SH2, is observed
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Fig. 5. Structure of the Syk-C: pTyr76
peptide complex. (a) Stereoview of the
superimposition of the backbone (N, Cot,
C) atoms of the final 20 structures of the
Syk-C: pTyr76 peptide, fitted using
residues 15-106 of Syk-C. The protein
residues belonging to x helices and
3 sheets are colored yellow and blue,
respectively. All other protein residues
are colored red and the pTyr76 peptide is
colored green. The Ca positions of
selected residues of the Syk-C protein are
indicated by sequence number. The
N and C termini of the pTyr76 peptide
are marked. (b) Ribbon illustration of the
restrained minimized mean structure of
the Syk-C complex. The backbone of the
protein (residues 15-108) is shown in
yellow. The heavy atoms of selected pro-
tein residue side chains are shown in red
and are labeled using the convention of
Eck et aL. [231. The peptide heavy atoms
are shown in blue. Protein secondary
structural elements are labeled as in Fig-
ure 1. The C terminus of the protein is
labeled C. The N-acetyl residue of the
peptide is excluded for clarity. The side
chains of the pTyr and Leu residues of
the pTyr76 peptide are labeled. (Figures
generated using the program QUANTA,
Version 4.1.)
at the C terminus of the structured region. Loop regions
are designated by the names of the secondary motifs that
they connect, according to convention. The BC loop
is the least-constrained portion of the structured region
(Fig. 5a).
The pTyr76 peptide lies in an extended conformation
on the surface of the protein, in the conventional plug
and socket orientation with respect to the protein [29].
The peptide straddles the 3D strand of the central 3
sheet, with the phosphotyrosine binding site being
formed by residues from helix aA and strands S3B, 13C,
and 3D. The side chain of the leucine (pTyr+3) residue
of the peptide is located in a pocket formed by residues
from the 3D strand, the otB helix, the BG loop and the
secondary 13 sheet. Figure 6 shows the superimposition
of the phosphopeptide and selected portions of the
peptide-binding site from the final 20 structures of the
complex.
Protein: peptide interactions
pTyr-binding site
The observed interactions between the pTyr residue and
the SH2 domain are summarized in Figure 7a. The pTyr
interacts with a positively charged region of the protein
that contains four arginine residues: ArgeaA2, Arg3B5,
Arg3B7 and ArgP3D6 (the last number referring to the
number of the residue within the structural
element:Fig. 1). The aromatic ring of pTyr lies close to the
3C and 3D strands (Fig. 6) and makes numerous NOE
contacts with residues AlaI3C3, His3D4 and Tyr3D5.
Complete side-chain assignments for arginine residues
in the binding site could not be obtained. No NOE
interaction was observed between the assigned side-
chain protons of the arginine residues of the protein and
the pTyr of the peptide. Under the present solution
conditions it is not feasible to obtain NOEs between the
arginine guanidinium groups and the tyrosine phosphate
1066 Structure 1995, Vol 3 No 10
group due to the absence of slowly exchanging protons
that could participate in putative NOEs. Under these
circumstances, the minimum requirement for observa-
tion of arginine :pTyr NOE interactions is that the pTyr
ring protons and the slowly and/or non-exchanging
arginine side-chain protons are only separated by short
distances, a condition which depends on the relative
orientation of the two groups. This is particularly
important for the conserved arginine residues ArgaoA2
and Arg3B5 which are known from crystallographic
studies to participate in a well defined hydrogen-bond-
ing network involving the phosphate group of the lig-
and. Some information about the phosphate:arginine
interactions can, however, be inferred from the calculated
structures as, in some of these, the positions of the
ArgolA2 and Argl3B5 side chains do allow for hydrogen
bonding of these residues with the phosphate group of
the peptide. In addition, the relative positions of the
backbone carbonyl group of pTyr-1 (Thrl) of the pep-
tide and the side chain of HisPD4 are similar to those
observed in crystallographic structures where the guani-
dinium group of ArgaoA2 is placed so that it forms
hydrogen bonds with both the carbonyl group of
pTyr-1 and the phosphate group of pTyr, and is also
involved in a charge-'7r interaction with the aromatic
ring of the pTyr [23,29]. Both ArgaoA2 and ArgB5 are
highly conserved in SH2 domains, therefore it is likely
that the interactions of residues ArgalA2 and ArgPB5
with the pTyr are very similar to those in other known
SH2 structures. The absence of NOEs between these
residues and the pTyr ring has been reported in NMR
studies of other SH2:peptide complexes. It has been
suggested that this lack of NOEs may result from
motional broadening and/or proton exchange phenom-
ena [27,30], and similar phenomena may be present in
Syk-C.
Less can be inferred about the interactions between pTyr
and the other two arginine residues in the pocket.
Arg3B7 is in the BC loop region of the domain, and the
lack of NOEs in this loop (Fig. 4) precludes definition of
its interactions with the pTyr residue. The apparent dis-
order in the BC loop region could be due to segmental
mobility, or to extension of the loop as observed in the
C-terminal SH2 domain of ZAP-70 (ZAP-C) [34].
NOEs between the 'pTyr ring and the CotH of ArgPD6
are observed, but in the calculated structures the side
chain of ArgPD6 is not well constrained.
Residues pTyr+l to pTyr+3
A summary of the NOE interactions between the protein
and residues pTyr+l(Glu3) to pTyr+3(Leu5) of the
peptide is shown in Figure 7b. The pTyr+l residue
shows NOE interactions with the aromatic ring of
Tyr3D5 and also with the side chain of Leu[3D3. In the
calculated structures, Glu3 lies on the protein surface
with its side chain lying in a shallow depression formed
by these tyrosine and leucine side chains (Fig. 6). The
amide proton of this glutamate residue points towards the
carbonyl oxygen of HisD4, indicative of a potential
hydrogen bond, although no corresponding constraint
was included in the structural calculations.
A large number of NOE interactions occur between
pTyr+3 and the protein (Fig. 7b), specifically with the
aromatic rings of Tyr3D5, GlyEF3, GlyBG3 and
LeuBG4, and the methyl groups of IleP3E4. The calcu-
lated structures show that the side chain of pTyr+3 is
buried in a pocket formed from the side chains of
TyrPD5, IleE4, TyrtB9 and LeuBG4 (Fig. 6).
The pTyr+2 (Thr4) residue shows few NOE interactions
with the protein, consequently its side chain is directed
away from the protein.
Table 1. Structural statistics of the final 20 structures of
Syk-C: pTyr76 peptide complex.
Structural statistics <SA>* (SA)r t
Rms deviations from the
NOE-derived distance restraints (A)
All (1514)* 0.076+0.002 0.073
Intraprotein distances (1340)* 0.076±0.002 0.073
Intrapeptide distances (63)* 0.081 0.011 0.084
Peptide:protein distances (55)* 0.097 ± 0.014 0.085
H-bonds (56)§ 0.036 ± 0.036 0.029
Rms deviations from experimental
dihedral restraints ()(48)* 0.846±0.174 0.671
Deviations from idealized geometry
Bonds(A) 0.0079 0.0002 0.0077
Angles( °) 1.150±0.017 1.130
Impropers(°) 0.892 ±0.024 0.879
The average rms deviations from the experimental and
covalent geometric restraints used for X-PLOR structure
calculations are listed. *The mean value for the 20 final
simulated annealing structures. tThe restrained minimized
mean structure, where the mean structure was obtained by
averaging the coordinates of the 20 individual superimposed
structures. The number of NMR restraints. A total of 56
restraints were used for 28 constrained H bonds.
Table 2. The average atomic rms deviations from the mean
structure of the Syk-C :pTyr76 peptide complex.
Atomic rms Backbone N, All non-hydrogen
deviations (A) Ca and C atoms atoms
Residues 15-106 (92)* 1.17+0.27 1.90±0.27
Central 13 sheet
(PB, 13C and 3D) (19)* 0.43 ± 0.10 1.13 0.17
Helix aA (10)* 0.17±0.06 1.06±0.26
Helix aB (12)* 0.09±0.04 0.69±0.19
pTyr76 peptide (5)* 0.24 0.11 1.09 ±0.19
Binding interface (14) 0.42±0.11 1.15+0.19
Helix aA includes residues 22-31, helix aB includes residues
83-94 and the central 13 sheet includes residues 38-43, 50-55
and 59-65. The binding interface includes the pTyr76
peptide, and protein residues: ArgP3B5, Ala3C3, Leul3D3,
His13D4, Tyr3D5, GlyEF3, llel3E4, GlyBG3 and Leu BG4.
*Number of residues.
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Fig. 6. Detailed view of the peptide-
binding site. The figure shows the super-
imposition of the heavy atoms from the
final 20 structures of the bound pTyr76
peptide and selected protein residues
that form the peptide-binding site . The
protein residues belonging to a helices
and 3 sheets are colored yellow and
purple, respectively, and all other pro-
tein residues are colored red. The
pTyr76 peptide is colored green. The
positions of the pTyr and Leu side
chains of the pTyr76 peptide are
marked. Protein residues are labeled
using the convention of Eck et al. 1231.
A total of 55 protein:peptide NOEs were observed, of
which 42 are associated with pTyr and pTyr+3. Of the
remainder, 11 protein:peptide NOEs are observed for
the pTyr+l and two for pTyr+2. No NOE interactions
between the protein and pTyr-1 (Thrl) were observed.
Discussion
Comparison with other SH2 domains
The structures of a number of SH2 domains, both in
the absence and presence of pTyr peptides, have been
solved by X-ray crystallography and NMR spec-
troscopy. Two liganded NMR structures have been
described - the phospholipase C-y-1 (PLC-yl) C-ter-
minal SH2 domain complexed with a hydrophobic pTyr
peptide derived from the platelet-derived growth factor
receptor [27] and the c-Src SH2 domain in com-
plex with a hydrophilic pTyr peptide [30]. This latter
structure is very similar to the prototype high-affinity
SH2: 'pTyr-Glu-Glu-Ile' peptide complex, v-Src:
(Glu- Pro- Gln- pTyr- Glu-Glu-Ile-Pro- Ile- Tyr- Leu),
which was solved crystallographically [29]. Of particular
relevance to the present work, however, is the crystallo-
graphic structure of the complex between the tandem
SH2 domains of the homologous tyrosine kinase, ZAP-
70, and a doubly phosphorylated ITAM [34]. In this
section we compare the present Syk-C: pTyr76 peptide
structure with those of the v-Src: pTyr-Glu-Glu-Ile
peptide and the ZAP-C: ITAM complexes.
Figure 8 depicts the overlaid Ca trace representations of
the restrained minimized mean structure of the
Syk-C:pTyr76 peptide obtained from NMR studies, the
high affinity v-Src: pTyr-Glu-Glu-Ile peptide crystal
structure and the crystal structure of ZAP-C when
present within ZAP-C: ITAM. Rms deviation values cal-
culated using main-chain heavy atoms in aA and aB
helices and the central 3 sheet are 1.16 A, when compar-
ing Syk-C with v-Src, and 0.98 A when comparing
Syk-C with ZAP-C. A similar calculation, using the
same set of main-chain heavy atoms, was performed on
the final 20 Syk-C complex structures, resulting in a rms
deviation of 0.57+0.13 A. It is also possible to calculate
the relative positions of the central 3 sheet and the two
helices in the structures. Using only the core portion of
the 3 sheet (residues 38-42, 50-55 and 60-65 in Syk-C)
to superimpose the three molecules, the mean Ca
distances in the central sheet are 0.44 A (between Syk-C
and v-Src), 0.37 A (between Syk-C and ZAP-C) and
0.23 A (between ZAP-C and v-Src). The mean Ca
distances in the core portions of the at helices (residues
22-30 and 84-91 in Syk-C) are 0.94 A and 1.58 A (for
Syk-C compared with v-Src aA and aB, respectively),
0.92 A and 1.24 A (for Syk-C compared with ZAP-C
atA and aB, respectively) and 0.46 A and 0.76 A (for
ZAP-C compared with v-Src axA and aB, respectively).
These differences indicate a slight change in the relative
orientation of the two a helices with respect to the
central 3 sheet in Syk-C compared with that found in
Src and ZAP-C. The degree of sequence identity
between Syk-C and v-Src is 41.3% and between Syk-C
and ZAP-C is 52.2%. Figure 8 shows that the overall
topology of the SH2 domain is well conserved between
the three structures, which is consistent with the modular
nature of the SH2 domain. Furthermore, this similarity
between the structures of the isolated SH2 domains
(v-Src and Syk-C) and the ZAP-C domain indicates that
the SH2:SH2 interactions observed in the tandem
structure do not perturb the fold of the individual SH2
domains [34].
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Fig. 7. Schematic illustrations of the
interactions of the pTyr76 peptide
residues with Syk-C. (a) pTyr:Syk-C
interactions. (b) Interactions of the
pTyr+1 (Glu3), pTyr+2 (Thr4), and
pTyr+3 (Leu5) residues with Syk-C. The
peptide residues are marked in oval,
whereas the protein residues are labeled
according to their name and position in
the secondary structure, and are marked
in rectangles (Fig. 1). Dashed lines
represent observed peptide :protein
NOEs, whereas dotted lines represent
inferred interactions (see text). In order
to simplify the figure, when multiple
NOE interactions from an amino-acid
side chain are present, curved lines
have been used to group side-chain
protons that have similar NOEs.
Figure 8 also shows that the greatest differences between
the structures lie in the loop regions linking the principal
structural elements. The shorter CD loop in Syk-C and
ZAP-C is consistent with a truncation of five amino
acids (Fig. 1). The BC and EF loops form parts of the
pTyr and pTyr+3 binding sites, respectively. The BC
loop in the Syk-C structure is poorly constrained as a
result of a lack of observed NOE interactions and partial
assignments. This lack of observed NOEs may result
from motional broadening and/or chemical exchange
phenomena. In the crystal structure of the homologous
ZAP-C, the BC loop adopts an 'open' conformation, in
comparison with the closed conformation in the proto-
typical v-Src structure. This difference can be seen in
Figure 8, where the closed BC loop in the v-Src struc-
ture lies closer than the open loop in ZAP-C to the pTyr
residue. This difference reflects an increased number of
direct BC loop: pTyr interactions in v-Src compared
with ZAP-C and may explain why individual SH2
domains of ZAP-70 show markedly lower affinities for
singly phosphorylated peptides [29,34,50-53]. The high
sequence identity between Syk and ZAP-70 suggests that
a similar situation may arise for Syk. The EF loop adopts
a different conformation in all three structures, with that
in the Syk-C complex lying closest to the BG loop. The
difference between Syk-C and ZAP-C in this region
may, arise from the presence of the larger peptide (that is
in contact with both tandem SH2 domains).
Phosphopeptide: SH2 NOE interactions have been
described for the PLC-yl and c-Src SH2 domains (Fig. 1).
A number of NOE interactions at the pTyr site are con-
served amongst the PLCy-1, c-Src and Syk-C domains;
these arise from the back of the pTyr-binding site and
involve residues at the 3C3, 3D4 and D5 positions.
Interactions in c-Src involving the BC loop residue BC2
and interactions in PLCy-1 involving residue 3B7, are not
observed in Syk-C. Interactions between the remainder of
the peptide and the SH2 domain are similar for Syk-C and
c-Src, which is consistent with their classification, on the
basis of ligand selectivity and sequence homology, as group
I SH2 domains. Common interactions at the pTyr+3 posi-
tion, for these two proteins, involve the 3D5, 3E4 and
BG4 residues. The EF1 residue interaction observed in
(a)
(b)
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|GlyEF3 
lie E4
I
/-
If
Syk tyrosine kinase Narula etal. 1069
occurs in the position of the pTyr+3 side chain. In
Syk-C, this side chain twists and moves more deeply into
the pTyr+3 pocket (Fig. 6), in contrast to the pTyr+3 side
chains in the v-Src and ZAP-C structures, and the EF
loop rearranges to close the gap between it and the BG
loop. It is worthwhile noting that other reported struc-
tural studies on SH2:peptide complexes, including those
discussed here, have used pTyr-containing peptides that
contain additional residues C-terminal to the pTyr+3 site.
Deeper burial of the pTyr+3 residue was also observed in
computer simulations of truncated peptides in complex
with v-Src (E Laird, personal communication).
Fig. 8. Superimposition of the restrained minimized mean struc-
tures of the Syk-C:pTyr76 peptide complex (red), the
v-Src:pTyr-Glu-Glu-lle' peptide complex (molecule 1 of the
asymmetric unit) (green) 129], and the ZAP-70 SH2 domain
(ZAP-C) present in the structure of the tandem ZAP-C:ITAM
complex (purple) [341. The Cot traces of the proteins are shown,
and the Coa trace of the bound peptides, along with the heavy
atoms of pTyr, are shown in licorice. For clarity, the Syk-C and
ZAP-C domains have been truncated to match those observed in
the prototype v-Src structure. For the v-Src SH2 structure, residues
pTyr-2 to pTyr+4 are shown in the bound peptide. In the case of
the ZAP-C structure, the bound peptide was truncated at the
pTyr+4 peptide, thus the bound peptide shows residues pTyr-3 to
pTyr+4. The structures were superimposed using the main-chain
atoms of consensus secondary structure regions in helices acA and
3A and the central 13 sheet (corresponding to residues 22-30,
38-43, 50-55, 59-65 and 83-94 in Syk-C). Residues in v-Src are
labeled using the nomenclature of Eck et al. [23].
c-Src is not observed in Syk-C, but interactions with the
EF3 and BG3 residues do appear. For the PLC-yl SH2
domain, these interactions are somewhat different, particu-
larly as this domain exhibits an extended peptide-binding
site and also has different peptide-binding selectivity
[35,36]. Although the pTyr+l peptide residue interacts
with the side chains of the D3 and 3D5 residues for all
three SH2 domains, the extended peptide-binding site in
PLC-yl generates a different set of interactions for
residues C-terminal to the pTyr+l site, that are not
directly comparable with those described above.
In summary, we have determined the solution structure
of the C-terminal SH2 domain of the tyrosine kinase
Syk, in complex with a phosphotyrosine pentapeptide
corresponding to the pTyr76 SH2-binding motif in the
y chain of the FceRI receptor, its native ligand. This is
the first reported structure of an SH2 domain from the
Syk tyrosine kinase. The overall topology of Syk-C is
very similar to other SH2 domains of known structure,
with the peptide:protein interaction following the
conventional plug and socket arrangement [29]. The
overall structural similarity between Syk-C and ZAP-C
suggests that the structure of Syk-C in the context of
tandem Syk is similar to that in isolation, and that the
isolated Syk-C is properly folded.
The BC loop is disordered in the present structure and
may be extended, as in the homologous ZAP-C. Disor-
dered and extended BC loops have been observed previ-
ously for uncomplexed SH2 domains [22,29] and in a
phosphonopeptide: SH2 complex [31]. 15N NMR relax-
ation studies on the PLC-yl SH2 domain have shown
that the BC loop residues in this domain exhibit
motions on a microsecond to millisecond time scale both
in the absence and presence of peptide [54]. It has been
suggested that the BC loop can act as if on hinges, allow-
ing both open and closed pTyr-binding sites. In the case
of Syk and ZAP-70, this may provide a mechanism to
modulate peptide-binding affinities and hence selectivity.
Although the overall topology of SH2 domains is
conserved, significant differences do exist in the loop
regions that are associated with the principal binding
sites. Natural peptide ligands are limited in their struc-
tural diversity and do not reveal the potential for selectiv-
ity of these domains. Bioavailable organic ligands that are
developed from exploitation of structural differences, as
well as diverse compound libraries, will expose this selec-
tivity and provide unique starting points for drug design.
In the Syk-C structure, the pTyr residue of the peptide is
bound in a very similar orientation to that observed for
the pTyr residues in the v-Src and ZAP-C crystal struc-
tures, with the exception of the disorder observed for the
phosphate group in the NMR structure. The pTyr+ 1 side
chain lies along the surface of the protein and the side
chain of pTyr+2 extends into solution. A larger difference
Biological implications
The binding of antigens to the cell-surface IgE
receptor on mast cells induces the manufacture
and release of cellular mediators. Early events in
this process involve the receptor-mediated activa-
tion of the non-receptor protein tyrosine kinases,
Lyn and Syk. The process occurs sequentially;
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activated Lyn phosphorylates tyrosines within the
cytoplasmic domain of the receptor, and this is
followed by the activation of Syk upon its associa-
tion with the phosphorylated-receptor complex.
Although the activation of the IgE receptor results
in the tyrosine phosphorylation of many cellular
proteins, Syk selectively associates with the IgE
receptor through its tandem Src homology 2
(SH2) domains. In order to understand the basis
of this selectivity, we have initiated a structural
characterization of the interaction between Syk
and the IgE receptor.
The overall topology of the Syk C-terminal SH2
domain (Syk-C) resembles that of other SH2
domains. Structural differences between Syk-C
and these other domains are apparent at the phos-
photyrosine (pTyr) pocket and the pTyr+3 site and
are likely determinants of the binding affinity and
selectivity of Syk-C. Syk binding, however, is also
influenced by the N-terminal SH2 domain
(Syk-N). Unlike proteins such as Src, that contain
a single SH2 and recognize many tyrosine-phos-
phorylated proteins, Syk and the closely related
ZAP-70 selectively recognize activated immune-
cell receptors. The structural characterization of
the tandem SH2 domains from the homologous
ZAP-70 revealed that selectivity is dependent on
the orientation of the two SH2 domains, inter-
actions between the domains, and binding inter-
actions with two appropriately spaced pTyr-X-X-
Leu motifs in immunoreceptor tyrosine based
activation motif (ITAM) ligands.
Although both SH2 domains in Syk and ZAP-70
are required for immune-cell signaling, the N- and
C-terminal SH2 domains appear to be functionally
distinct. In vitro binding studies on isolated SH2
domains of Syk demonstrate that Syk-C, but not
Syk-N, binds to the IgE receptor complex, albeit
with weaker affinity than the tandem Syk SH2
domains. The structure of Syk-C presented here, its
similarity to ZAP-C, together with the recently
determined crystal structure of the tandem SH2
domains of ZAP-70, provide evidence that these
N- and C-terminal SH2 domains are structurally
distinct. These N- and C-terminal SH2 domains in
Syk and ZAP-70 must therefore contribute in
different ways to achieve the selectivity exhibited by
SH2 domains that exist in tandem.
The structure of the Syk-C complex presented here
will be useful in the development of Syk inhibitors.
As both Syk SH2 domains are critical for associa-
tion of Syk with activated IgE receptors and the
subsequent release of mast-cell mediators, agents
that block the association of a single SH2 domain
with the ITAMs should be effective for treating
chronic conditions such as allergy and asthma.
Materials and methods
Protein expression and purification
The C-terminal SH2 domain of human Syk (human Syk-C),
encoding residues 163-265, was cloned into the pGEX2TK
expression vector and transformed into E. coli BL21(DE3)
[20,55]. The protein used for NMR analysis contained a total
of 112 amino acids, which included 9 non-Syk amino acids at
the N terminus. Trpl5 in the present construct is equivalent to
Trpl68 in human Syk-C. Isotopically labeled glutathione-S-
transferase (GST)-Syk-C was produced from the growth and
induction of two liters of culture in M9 medium supplemented
with 1 g L-1 of 15NH 4C1 and/or 3 g L- l of 13C glucose, to
obtain uniformly labeled Syk-C. The fractionally labeled
(-10%) 13C Syk-C sample was prepared by supplementing the
M9 medium with 4.15 g L-1 of a mixture containing a 9:1
ratio of unlabeled glucose:13C glucose, just before induction.
In a typical preparation, the culture was grown at 250C to an
optical density (OD) of 1.0, at 595 nm, induced with 1 mM
isopropyl-3-D-thiogalactopyranoside (IPTG), and harvested
five hours later. The cells were lysed using a French pressure
cell and the protein was affinity purified over glutathione
agarose. The GST fusion protein was cleaved with thrombin
and further purified over phosphotyrosine agarose and polyeth-
yleneimine ion exchange resin to yield, by sodium dodecyl
sulfate (SDS) gel electrophoresis, an SH2 domain that was
>98% pure . N-terminal sequencing and mass-spectroscopic
analysis confirmed the expected sequence.
Peptide synthesis
Peptides were synthesized by automated solid-phase synthesis
using N-fluorenylmethoxycarbonyl amino acids. Phosphoryla-
tion of the tyrosine residues was accomplished by the global
phosphorylation method [56,57]. The peptides were purified
by gel filtration and reverse phase high pressure liquid
chromatography (HPLC) to a purity greater than 98%.
Measurement of relative peptide affinities
Relative peptide affinities (Fig. 2) were determined by competi-
tion using surface plasmon resonance (BlAcore Biosensor, Phar-
macia Biosensor, Piscataway, NJ). Syk-C (270 nM) was
pre-incubated with various concentrations (0.1-1000 pM) of
ITAM-derived phosphopeptides in HEPES-buffered saline
(HBS) (10 mM HEPES pH 7.4, 150 mM NaCl, 3.4 mM
EDTA, 0.05% Tween 20) for >1 hour, at 40C, and binding to
the monophosphorylated FceRIy ITAM peptide
(Ac-Lys-Gly-Gly-Asp-Gly-Val-pTyr-Thr-Gly-Leu-Ser-Thr
-Arg-Asn-Gln-Glu-Thr-Tyr-Glu-Thr-Leu-Lys-NH 2) was
measured by surface plasmon resonance at 250C, at a flow rate
of 5 pl min-'. In all cases, binding equilibrium was achieved.
The percent of inhibition was calculated with reference to
binding in the absence of inhibitor and IC50s determined from
secondary plots of percent inhibition versus inhibitor concentra-
tion. The y-chain ITAM peptide (120 RU) was covalently
immobilized to a Biosensor Chip CM5 (Pharmacia Biosensor)
through the -amino group of the lysyl residue, as previously
described [58]. The chip was regenerated between assays using a
1 min pulse of 6 M guanidine hydrochloride (pH 7.0). No loss
of bound peptide was detected after more than 200 regenera-
tions as measured by binding of an anti-phosphotyrosine mono-
clonal antibody. All measurements were corrected for bulk
refractive index errors using a sham-coupled flow cell.
Complex preparation
Syk-C: pTyr76 peptide samples were prepared by adding
a twofold molar excess of the pTyr76 peptide
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(Ac-Thr-pTyr-Glu-Thr-Leu-NH 2) dissolved in 0.5 ml
NMR buffer (50 mM Tris-d1ll, 0.15 N NaCI, 10 mM DTT-
dlo, 0.025% NaN3, pH 7.0) to.the Syk-C protein dissolved in
the same buffer. This mixture was incubated overnight at 8°C
and then concentrated and further equilibrated using Centri-
conlO microconcentrators (Amicon, Beverly, MA) at 140C.
Five exchanges of buffer, 2 ml-200 ml, ensured complete
equilibration. Aliquots of the filtrate and the final complex
solution were taken and analyzed by HPLC. All NMR samples
contained 2-4 mM protein complex.
NMR techniques
Several NMR samples were utilized during the NMR assign-
ment procedure. Protein complexes containing singly labeled
('5 N) Syk-C in H20 (90%)/ D20 (10%); doubly labeled
('5N/13 C) Syk-C in H20 (90%)/ D20 (10%) and 99% D20;
fractionally labeled ( 3C) Syk-C in 99% D20: and unlabeled
Syk-C in 99% D20, were prepared in the buffer described
above. NMR experiments were performed on a Bruker
AMX600 spectrometer equipped with triple resonance probe, at
200C. NMR spectra were processed using UXNMR (Bruker
Instruments, Billerica, MA) and NMRPipe software (Molecular
Simulations, Burlington, MA), and analyzed using the NMR-
Compass program (Molecular Simulations, Burlington, MA) on
SGI Indigo-2 and Crimson workstations. Assignment of the pro-
tein H, 13C and 15N resonances was achieved by means of
through-bond heteronuclear correlations along the backbone
and side chains with the following experiments: H-I5 N
TOCSY-HMQC, HNCA, CBCANH, CBCA(CO)NH,
HBHA(CO)NH, H(CCO)NH, HCCH-correlated spec-
troscopy (COSY) and HCCH-TOCSY, to demonstrate
CotH(i)/CPH(i)-15N(i) -NH(i), 13Cao(i-1)- 5N(i)-NH(i)
and 3 Cao(i)-' 5 N(i)-NH(i), 1 3CP/Cot(i)-' 5N(i)-NH(i) and
13CP/CaO(i-l_)-sN(i)-NH(i), 3Cp/Cat(i-l)-15N(i)-NH(i), 13
CPH(i-1)/13 CaH(i-1)-' 5 (i)-NH(i), H (i-1)-' 5N(i)-NH(i),
and Hj.- 3C -13 C -H +n correlations, respectively (i refers to
the residue number and j to the carbon position along a side
chain), together with comparisons with our previous assignments
of unliganded Syk-C [41,42,59-64]. The determination of
amino-acid type was on the basis of chemical shifts of Cot and
CP [43]. Quantitative 3JHNa couplings for protein residues were
measured from a 3D HNHA spectrum [48]. Stereospecific
assignments of the diastereotopic methyl groups of the valine and
leucine residues of the protein were made using a protein com-
plex prepared with fractionally 13C labeled Syk-C. Protein
aromatic assignments were obtained using a combination of
homonuclear 2D correlation experiments on unlabeled-protein
complex and heteronuclear 2D (H3)C,(C yC8)Ho and
(HP3)C(CyC8CE)HE experiments carried out on the
'
5 N/ 13C-labeled protein complex [65]. Spectra recorded for
obtaining distance constraints included 100 ms mixing time, 3D
15N-edited NOESY-HMQC and a 100 ms mixing time, 3D
13C-edited NOESY-HMQC [66,67]. A 4D, 15N-13C-edited
NOESY-HMQC, with 100 ms mixing time, was used to
resolve some of the resonance overlaps observed for the 3D
'
5N-edited NOESY-HMQC [68]. The water resonance was
saturated in some experiments during the relaxation delay, using
low power decoupler irradiation. Qualitative amide proton
exchange rates were obtained by acquiring 2D H-15 N HSQC
spectra on a sample freshly exchanged into D20 [40].
1H assignments of the bound pTyr76 peptide resonances were
obtained using a combination of 2D isotope-filtered experiments
on a samples of the complex prepared with t5N/13 C labeled
Syk-C in H20 (90%)/ D20 (10%) and 99% D20 buffers
[38,46]. Intrapeptide distance constraints were obtained from 2D
'
5 N/13 C and 2D 13C/13C isotope-filtered NOESY experiments
[38,47]. Peptide: protein distance constraints were obtained from
2D isotope-filtered 13C/13C NOESY experiments (100 ms mix-
ing time) [47] and from a 3D 13C HMQC-NOESY isotope
filtered experiment with a 100 ms mixing time. One peptide X1
value was constrained on the basis of the intraresidue NOE
intensities and qualitative coupling constant data.
Structure calculations
The structures were calculated with a hybrid distance geo-
metry/simulated-annealing protocol using the program X-
PLOR 3.1 [49]. The target function that is minimized during
simulated annealing comprises only quadratic harmonic poten-
tial terms for covalent geometry, soft-square well quadratic
potentials for the experimental-distance constraints and a har-
monic potential for the coupling-constant constraints. Calcula-
tions included 1514 NOE-derived distance constraints,
classified into three distance ranges [69], 47 protein 4) angular
constraints derived from 3JHN coupling constants, and one
peptide X1 constraint. Center averaging of distances involving
methylene and methyl protons was used, with appropriate cor-
rections made to the distance constraints [69]. Hydrogen-
bonding constraints, on the basis of qualitative backbone amide
proton water exchange rates, were included in the refinement
step after analyzing the preliminary structures. Each of the 28
hydrogen-bond constraints were defined as two NOE distance
constraints: rNHO, 1.6-2.4 A; rN-0, 2.6-3.4 A. The final 20
structures with lowest energy and no violations of NOEs
greater than 0.5 A and angular constraints greater than 50, were
selected. The mean structure was generated by averaging the
coordinates of the final 20 structures. This structure was then
refined to obtain the restrained minimized mean structure
using simulated annealing.
The coordinates of the final 20 structures, as well as the
restrained minimized mean structure, will be deposited in the
Brookhaven Protein Data Bank.
Note added in proof
The solution structure of the Shc SH2 domain in complex with
a phosphotyrosine has recently been reported (Zhou, M. -M.,
et al. & Fesik, S.W. (1995). Solution structure of the Shc SH2
domain complexed with a tyrosine-phosphorylated peptide from
the T-cell receptor. Proc. Natl. Acad. Sci. USA 92, 7784-7788).
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